
|Articles|December 1, 2003
CMS Ready to Impose Plan Reform
Dermatologists who administer chemotherapy and other drugs in their offices could see significant reductions in reimbursement levels as a result of an effort by the federal government to curtail Medicare's costs for drugs used to treat cancer.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Chronic Hand Eczema: Treatment Gaps, New Options, and Clinical Trial End Points
2
David Rosmarin, MD, on CHE Heterogeneity and Unmet Needs in AD and Vitiligo
3
Clinique's Daily Calm Merges Clinical Efficacy with Color Cosmetics for Sensitive Skin
4
First HA Injectable for Neck Wrinkles Cleared by FDA
5












